troglitazone has been researched along with Bone Cancer in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In our study, we investigated whether treatment with troglitazone (TRO), a known PPAR gamma agonist, induced apoptosis in the human osteosarcoma (OS) cell lines G292, MG63, SAOS and U2OS that express PPAR gamma." | 3.71 | Troglitazione affects survival of human osteosarcoma cells. ( Alessandra Gobbi, G; Lattanzi, G; Lucarelli, E; Maini, V; Marmiroli, S; Mordenti, M; Picci, P; Reggiani, M; Sangiorgi, L; Scrimieri, F; Zambon Bertoja, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lucarelli, E | 1 |
| Sangiorgi, L | 1 |
| Maini, V | 1 |
| Lattanzi, G | 1 |
| Marmiroli, S | 1 |
| Reggiani, M | 1 |
| Mordenti, M | 1 |
| Alessandra Gobbi, G | 1 |
| Scrimieri, F | 1 |
| Zambon Bertoja, A | 1 |
| Picci, P | 1 |
1 other study available for troglitazone and Bone Cancer
| Article | Year |
|---|---|
Troglitazione affects survival of human osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Count; Cell Division; Cell | 2002 |